![]() | Up a level |
Article
Tareque, Raysa Kahn, Hassell-Hart, Storm, Krojer, Tobias, Bradley, Anthony, Velupillai, Srikannathasan, Talon, Romain, Fairhead, Michael, Day, Iain J, Bala, Kamlesh, Felix, Robert, Kemmitt, Paul, Brennan, Paul, von Delft, Frank, Díaz Sáez, Laura, Spencer, John and Huber, Kilian (2020) Deliberately losing control of C-H activation processes in the design of small molecule fragment arrays targeting peroxisomal metabolism. ChemMedChem. ISSN 1860-7179
Sandham, David A, Arnold, Nicola, Aschauer, Heinrich, Bala, Kamlesh, Barker, Lucy, Brown, Lyndon, Brown, Zarin, Budd, David, Cox, Brian, Docx, Cerys, Dubois, Gerald, Duggan, Nicholas, England, Karen, Everatt, Brian, Furegati, Marcus, Hall, Edward, Kalthoff, Frank, King, Anna, Leblanc, Catherine J, Manini, Jodie, Meingassner, Josef, Profit, Rachael, Schmidt, Alfred, Simmons, Jennifer, Sohal, Bindi, Stringer, Rowan, Thomas, Matthew, Turner, Katharine L, Walker, Christoph, Watson, Simon J, Westwick, John, Willis, Jennifer, Williams, Gareth and Wilson, Caroline (2013) Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases. Bioorganic and Medicinal Chemistry, 21 (21). pp. 6582-6591. ISSN 0968-0896
Sandham, David A, Adcock, Claire, Bala, Kamlesh, Barker, Lucy, Brown, Zarin, Dubois, Gerald, Budd, David, Cox, Brian, Fairhurst, Robin A, Furegati, Markus, Leblanc, Catherine, Manini, Jodie, Profit, Rachael, Reilly, John, Stringer, Rowan, Schmidt, Alfred, Turner, Katharine L, Watson, Simon J, Willis, Jennifer, Williams, Gareth and Wilson, Caroline (2009) 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists. Bioorganic and Medicinal Chemistry Letters, 19 (16). pp. 4794-4798. ISSN 0960-894X
Patent
Novartis AG, Bala, K J, Cox, B et al (2006) Organic compounds for the treatment of imflammatory or alleric conditions. WO2006125596.
Novartis AG, Bala, K, Cox, B et al (2005) Pyrrolopyridine derivatives and their use as CRTh2 antagonists. WO/2005/123731.